|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.652
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.470
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.440
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.406
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.400
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.400
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.350
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.348
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.321
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.315
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.311
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.303
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.301
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.295
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.292
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.289
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.286
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.271
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.265
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.250
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.244
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.238
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.233
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.233
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.230
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.226
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.221
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.214
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.214
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.206
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.206
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.202
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.202
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.198
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.198
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.195
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.195
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.190
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.188
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.180
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.178
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.177
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.174
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.171
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.169
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.168
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.165
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.163
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.163
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.157
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.151
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.145
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.145
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.145
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.144
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.143
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.141
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.141
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.138
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.137
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.137
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.137
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.134
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.132
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.130
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.130
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.127
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.127
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.126
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.126
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.125
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.123
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.121
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.120
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.119
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.118
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.116
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.115
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.114
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.114
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.113
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.113
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.113
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.110
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.110
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.108
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.106
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.106
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.106
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.104
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.102
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.100
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.100
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.100
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.099
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.096
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.096
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.096
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.096
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.095
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.095
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.093
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.093
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.093
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.093
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.093
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.092
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.091
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.091
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.091
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.090
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.090
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.089
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.089
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.088
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.088
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.087
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.087
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.087
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.085
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.084
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.084
|
|
|
|
positive regulation of sodium ion export
|
GO:1903275 |
1 |
0.083
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.083
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.082
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.082
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.081
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.081
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.081
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.081
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.079
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.079
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.078
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.078
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.077
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.076
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.076
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.075
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.075
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.074
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.074
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.074
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.073
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.073
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.073
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.073
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.072
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.071
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.070
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.070
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.070
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.069
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.069
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.068
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.068
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.067
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.066
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.066
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.066
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.066
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.066
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.065
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.065
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.064
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.064
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.064
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.063
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.063
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.063
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.063
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.062
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.062
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.062
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.062
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.062
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.061
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.061
|
Human |
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.061
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.061
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.060
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.060
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.060
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.059
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.059
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.059
|
Human |
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.059
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.059
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.058
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.058
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.058
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.058
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.057
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.057
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.057
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.057
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.057
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.057
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.057
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.057
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.057
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.056
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.056
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.056
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.056
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.056
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.056
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.055
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.055
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.055
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.055
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.055
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.055
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.054
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.054
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.054
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.053
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.053
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.053
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.052
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.052
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.052
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.052
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.052
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.052
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.052
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.051
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.051
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.051
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.051
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.051
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.051
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.050
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.050
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.050
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.049
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.049
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.049
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.049
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.048
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.048
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.048
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.048
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.047
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.047
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.047
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.047
|
|
|
|
positive regulation of hair cycle
|
GO:0042635 |
7 |
0.047
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.046
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.046
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.046
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.046
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.046
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.046
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.046
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.045
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.045
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.045
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.045
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.045
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.045
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.044
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.044
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.044
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.044
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.044
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.044
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.044
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.044
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.044
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.044
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.044
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.043
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.043
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.042
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.042
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.042
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.042
|
Human |
|
|
telencephalon development
|
GO:0021537 |
186 |
0.042
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.041
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.041
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.041
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.041
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.041
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.040
|
|
|
|
regulation of establishment of planar polarity involved in neural tube closure
|
GO:0090178 |
15 |
0.040
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.040
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.040
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.040
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.040
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.040
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.040
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.039
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.039
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.039
|
|
|
|
branch elongation involved in salivary gland morphogenesis
|
GO:0060667 |
2 |
0.038
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.038
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.038
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.038
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.038
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.038
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.038
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.038
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.038
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.038
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.038
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.038
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.037
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.037
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.037
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.037
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.037
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.037
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.037
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.037
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.036
|
|
|
|
mammary gland bud formation
|
GO:0060615 |
2 |
0.036
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.036
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.036
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.036
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.036
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.036
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.036
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.035
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.035
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.035
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.035
|
|
|
|
lateral sprouting from an epithelium
|
GO:0060601 |
13 |
0.035
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.035
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.035
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.035
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.035
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.035
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.035
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.034
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.034
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.034
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.034
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.033
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.033
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.033
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.033
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.033
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.033
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.033
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.033
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.032
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.032
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.032
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.032
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.032
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.032
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.032
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.032
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.032
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.031
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.031
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.031
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.031
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.031
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.031
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.031
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.031
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.031
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.031
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.031
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.030
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
28 |
0.030
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.030
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.030
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.030
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.030
|
|
|
|
positive regulation of meiosis
|
GO:0045836 |
14 |
0.030
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.030
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.030
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.030
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.030
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.030
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.030
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.030
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.030
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.030
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.030
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.030
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.030
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.030
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.030
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.030
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.029
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by extracellular matrix epithelial cell signaling
|
GO:0060668 |
1 |
0.029
|
|
|
|
metanephric tubule morphogenesis
|
GO:0072173 |
9 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.029
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.029
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.029
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.029
|
|
|
|
fungiform papilla development
|
GO:0061196 |
6 |
0.029
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.029
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.029
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.029
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.029
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.029
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.029
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.029
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.029
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.029
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.028
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.028
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.028
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
|
hyperosmotic response
|
GO:0006972 |
4 |
0.028
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.028
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.028
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.028
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.028
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.028
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.028
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.028
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.028
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.028
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.028
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.027
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.027
|
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.027
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.027
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.027
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.027
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.027
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.027
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.027
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.027
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.027
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.027
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.026
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.026
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.026
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.026
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.026
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.026
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.026
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.026
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.026
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.026
|
|
|
|
mesonephric duct development
|
GO:0072177 |
5 |
0.026
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.026
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.026
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.026
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.026
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.026
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.026
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.026
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.025
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.025
|
|
